Race Oncology Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported net loss was AUD 5.66 million compared to AUD 4.41 million a year ago. Basic loss per share from continuing operations was AUD 0.0346 compared to AUD 0.0274 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 AUD | +1.55% | -4.38% | +55.95% |
Mar. 26 | Race Oncology Obtains Certificate of Analysis for RC220; Shares Up Almost 6% | MT |
Mar. 18 | Race Oncology Limited(ASX:RAC) dropped from S&P/ASX All Ordinaries Index | CI |
1st Jan change | Capi. | |
---|---|---|
+55.95% | 142M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RAC Stock
- News Race Oncology Limited
- Race Oncology Limited Reports Earnings Results for the Half Year Ended December 31, 2023